0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Erectile Dysfunction Oral Medications - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-37R12470
Home | Market Reports | Health| Reproductive Health
Global Erectile Dysfunction Oral Medications Market Research Report 2022
BUY CHAPTERS

Erectile Dysfunction Oral Medications - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-37R12470
Report
December 2024
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Erectile Dysfunction Oral Medications - Market Size

The global market for Erectile Dysfunction Oral Medications was estimated to be worth US$ 131 million in 2023 and is forecast to a readjusted size of US$ 166.9 million by 2030 with a CAGR of 3.6% during the forecast period 2024-2030

Erectile Dysfunction Oral Medications - Market

Erectile Dysfunction Oral Medications - Market

Sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis) and avanafil (Stendra) are oral medications that reverse erectile dysfunction by enhancing the effects of nitric oxide, a natural chemical your body produces that relaxes muscles in the penis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Oral Medications, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Erectile Dysfunction Oral Medications by region & country, by Type, and by Application.
The Erectile Dysfunction Oral Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Oral Medications.
Market Segmentation

Scope of Erectile Dysfunction Oral Medications - Market Report

Report Metric Details
Report Name Erectile Dysfunction Oral Medications - Market
Forecasted market size in 2030 US$ 166.9 million
CAGR 3.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Sildenafil
  • Tadalafil
  • Others
Segment by Application
  • Hospital Pharmacies
  • Private Clinics
  • Retail Pharmacies
  • E-Commerce
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eli Lilly, Pfizer, Bayer, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, Seoul Pharma, BaiYunShan General Factory, Yabang Pharmacy
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Erectile Dysfunction Oral Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Erectile Dysfunction Oral Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Erectile Dysfunction Oral Medications in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Erectile Dysfunction Oral Medications - Market size in 2030?

Ans: The Erectile Dysfunction Oral Medications - Market size in 2030 will be US$ 166.9 million.

Who are the main players in the Erectile Dysfunction Oral Medications - Market report?

Ans: The main players in the Erectile Dysfunction Oral Medications - Market are Eli Lilly, Pfizer, Bayer, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, Seoul Pharma, BaiYunShan General Factory, Yabang Pharmacy

What are the Application segmentation covered in the Erectile Dysfunction Oral Medications - Market report?

Ans: The Applications covered in the Erectile Dysfunction Oral Medications - Market report are Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce

What are the Type segmentation covered in the Erectile Dysfunction Oral Medications - Market report?

Ans: The Types covered in the Erectile Dysfunction Oral Medications - Market report are Sildenafil, Tadalafil, Others

1 Market Overview
1.1 Erectile Dysfunction Oral Medications Product Introduction
1.2 Global Erectile Dysfunction Oral Medications Market Size Forecast
1.2.1 Global Erectile Dysfunction Oral Medications Sales Value (2019-2030)
1.2.2 Global Erectile Dysfunction Oral Medications Sales Volume (2019-2030)
1.2.3 Global Erectile Dysfunction Oral Medications Sales Price (2019-2030)
1.3 Erectile Dysfunction Oral Medications Market Trends & Drivers
1.3.1 Erectile Dysfunction Oral Medications Industry Trends
1.3.2 Erectile Dysfunction Oral Medications Market Drivers & Opportunity
1.3.3 Erectile Dysfunction Oral Medications Market Challenges
1.3.4 Erectile Dysfunction Oral Medications Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Erectile Dysfunction Oral Medications Players Revenue Ranking (2023)
2.2 Global Erectile Dysfunction Oral Medications Revenue by Company (2019-2024)
2.3 Global Erectile Dysfunction Oral Medications Players Sales Volume Ranking (2023)
2.4 Global Erectile Dysfunction Oral Medications Sales Volume by Company Players (2019-2024)
2.5 Global Erectile Dysfunction Oral Medications Average Price by Company (2019-2024)
2.6 Key Manufacturers Erectile Dysfunction Oral Medications Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Erectile Dysfunction Oral Medications Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Erectile Dysfunction Oral Medications
2.9 Erectile Dysfunction Oral Medications Market Competitive Analysis
2.9.1 Erectile Dysfunction Oral Medications Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Erectile Dysfunction Oral Medications Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Oral Medications as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sildenafil
3.1.2 Tadalafil
3.1.3 Others
3.2 Global Erectile Dysfunction Oral Medications Sales Value by Type
3.2.1 Global Erectile Dysfunction Oral Medications Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Erectile Dysfunction Oral Medications Sales Value, by Type (2019-2030)
3.2.3 Global Erectile Dysfunction Oral Medications Sales Value, by Type (%) (2019-2030)
3.3 Global Erectile Dysfunction Oral Medications Sales Volume by Type
3.3.1 Global Erectile Dysfunction Oral Medications Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Erectile Dysfunction Oral Medications Sales Volume, by Type (2019-2030)
3.3.3 Global Erectile Dysfunction Oral Medications Sales Volume, by Type (%) (2019-2030)
3.4 Global Erectile Dysfunction Oral Medications Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Private Clinics
4.1.3 Retail Pharmacies
4.1.4 E-Commerce
4.2 Global Erectile Dysfunction Oral Medications Sales Value by Application
4.2.1 Global Erectile Dysfunction Oral Medications Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Erectile Dysfunction Oral Medications Sales Value, by Application (2019-2030)
4.2.3 Global Erectile Dysfunction Oral Medications Sales Value, by Application (%) (2019-2030)
4.3 Global Erectile Dysfunction Oral Medications Sales Volume by Application
4.3.1 Global Erectile Dysfunction Oral Medications Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Erectile Dysfunction Oral Medications Sales Volume, by Application (2019-2030)
4.3.3 Global Erectile Dysfunction Oral Medications Sales Volume, by Application (%) (2019-2030)
4.4 Global Erectile Dysfunction Oral Medications Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Erectile Dysfunction Oral Medications Sales Value by Region
5.1.1 Global Erectile Dysfunction Oral Medications Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Erectile Dysfunction Oral Medications Sales Value by Region (2019-2024)
5.1.3 Global Erectile Dysfunction Oral Medications Sales Value by Region (2025-2030)
5.1.4 Global Erectile Dysfunction Oral Medications Sales Value by Region (%), (2019-2030)
5.2 Global Erectile Dysfunction Oral Medications Sales Volume by Region
5.2.1 Global Erectile Dysfunction Oral Medications Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Erectile Dysfunction Oral Medications Sales Volume by Region (2019-2024)
5.2.3 Global Erectile Dysfunction Oral Medications Sales Volume by Region (2025-2030)
5.2.4 Global Erectile Dysfunction Oral Medications Sales Volume by Region (%), (2019-2030)
5.3 Global Erectile Dysfunction Oral Medications Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Erectile Dysfunction Oral Medications Sales Value, 2019-2030
5.4.2 North America Erectile Dysfunction Oral Medications Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Erectile Dysfunction Oral Medications Sales Value, 2019-2030
5.5.2 Europe Erectile Dysfunction Oral Medications Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Erectile Dysfunction Oral Medications Sales Value, 2019-2030
5.6.2 Asia Pacific Erectile Dysfunction Oral Medications Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Erectile Dysfunction Oral Medications Sales Value, 2019-2030
5.7.2 South America Erectile Dysfunction Oral Medications Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Erectile Dysfunction Oral Medications Sales Value, 2019-2030
5.8.2 Middle East & Africa Erectile Dysfunction Oral Medications Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Erectile Dysfunction Oral Medications Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Erectile Dysfunction Oral Medications Sales Value
6.2.1 Key Countries/Regions Erectile Dysfunction Oral Medications Sales Value, 2019-2030
6.2.2 Key Countries/Regions Erectile Dysfunction Oral Medications Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Erectile Dysfunction Oral Medications Sales Value, 2019-2030
6.3.2 United States Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Erectile Dysfunction Oral Medications Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Erectile Dysfunction Oral Medications Sales Value, 2019-2030
6.4.2 Europe Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Erectile Dysfunction Oral Medications Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Erectile Dysfunction Oral Medications Sales Value, 2019-2030
6.5.2 China Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
6.5.3 China Erectile Dysfunction Oral Medications Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Erectile Dysfunction Oral Medications Sales Value, 2019-2030
6.6.2 Japan Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Erectile Dysfunction Oral Medications Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Erectile Dysfunction Oral Medications Sales Value, 2019-2030
6.7.2 South Korea Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Erectile Dysfunction Oral Medications Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Erectile Dysfunction Oral Medications Sales Value, 2019-2030
6.8.2 Southeast Asia Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Erectile Dysfunction Oral Medications Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Erectile Dysfunction Oral Medications Sales Value, 2019-2030
6.9.2 India Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
6.9.3 India Erectile Dysfunction Oral Medications Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Information
7.1.2 Eli Lilly Introduction and Business Overview
7.1.3 Eli Lilly Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Eli Lilly Erectile Dysfunction Oral Medications Product Offerings
7.1.5 Eli Lilly Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Information
7.2.2 Pfizer Introduction and Business Overview
7.2.3 Pfizer Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Pfizer Erectile Dysfunction Oral Medications Product Offerings
7.2.5 Pfizer Recent Development
7.3 Bayer
7.3.1 Bayer Company Information
7.3.2 Bayer Introduction and Business Overview
7.3.3 Bayer Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Bayer Erectile Dysfunction Oral Medications Product Offerings
7.3.5 Bayer Recent Development
7.4 S.K. Chemicals
7.4.1 S.K. Chemicals Company Information
7.4.2 S.K. Chemicals Introduction and Business Overview
7.4.3 S.K. Chemicals Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2019-2024)
7.4.4 S.K. Chemicals Erectile Dysfunction Oral Medications Product Offerings
7.4.5 S.K. Chemicals Recent Development
7.5 Teva Pharma
7.5.1 Teva Pharma Company Information
7.5.2 Teva Pharma Introduction and Business Overview
7.5.3 Teva Pharma Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Teva Pharma Erectile Dysfunction Oral Medications Product Offerings
7.5.5 Teva Pharma Recent Development
7.6 Dong-A ST
7.6.1 Dong-A ST Company Information
7.6.2 Dong-A ST Introduction and Business Overview
7.6.3 Dong-A ST Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Dong-A ST Erectile Dysfunction Oral Medications Product Offerings
7.6.5 Dong-A ST Recent Development
7.7 Petros Pharmaceuticals
7.7.1 Petros Pharmaceuticals Company Information
7.7.2 Petros Pharmaceuticals Introduction and Business Overview
7.7.3 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Product Offerings
7.7.5 Petros Pharmaceuticals Recent Development
7.8 Seoul Pharma
7.8.1 Seoul Pharma Company Information
7.8.2 Seoul Pharma Introduction and Business Overview
7.8.3 Seoul Pharma Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Seoul Pharma Erectile Dysfunction Oral Medications Product Offerings
7.8.5 Seoul Pharma Recent Development
7.9 BaiYunShan General Factory
7.9.1 BaiYunShan General Factory Company Information
7.9.2 BaiYunShan General Factory Introduction and Business Overview
7.9.3 BaiYunShan General Factory Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2019-2024)
7.9.4 BaiYunShan General Factory Erectile Dysfunction Oral Medications Product Offerings
7.9.5 BaiYunShan General Factory Recent Development
7.10 Yabang Pharmacy
7.10.1 Yabang Pharmacy Company Information
7.10.2 Yabang Pharmacy Introduction and Business Overview
7.10.3 Yabang Pharmacy Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Yabang Pharmacy Erectile Dysfunction Oral Medications Product Offerings
7.10.5 Yabang Pharmacy Recent Development
8 Industry Chain Analysis
8.1 Erectile Dysfunction Oral Medications Industrial Chain
8.2 Erectile Dysfunction Oral Medications Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Erectile Dysfunction Oral Medications Sales Model
8.5.2 Sales Channel
8.5.3 Erectile Dysfunction Oral Medications Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Erectile Dysfunction Oral Medications Market Trends
    Table 2. Erectile Dysfunction Oral Medications Market Drivers & Opportunity
    Table 3. Erectile Dysfunction Oral Medications Market Challenges
    Table 4. Erectile Dysfunction Oral Medications Market Restraints
    Table 5. Global Erectile Dysfunction Oral Medications Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Erectile Dysfunction Oral Medications Revenue Market Share by Company (2019-2024)
    Table 7. Global Erectile Dysfunction Oral Medications Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Erectile Dysfunction Oral Medications Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Erectile Dysfunction Oral Medications Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Erectile Dysfunction Oral Medications Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Erectile Dysfunction Oral Medications Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Erectile Dysfunction Oral Medications
    Table 13. Global Erectile Dysfunction Oral Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Oral Medications as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Erectile Dysfunction Oral Medications Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Erectile Dysfunction Oral Medications Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Erectile Dysfunction Oral Medications Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Erectile Dysfunction Oral Medications Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Erectile Dysfunction Oral Medications Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Erectile Dysfunction Oral Medications Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Erectile Dysfunction Oral Medications Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Erectile Dysfunction Oral Medications Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Erectile Dysfunction Oral Medications Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Erectile Dysfunction Oral Medications Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Erectile Dysfunction Oral Medications Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Erectile Dysfunction Oral Medications Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Erectile Dysfunction Oral Medications Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Erectile Dysfunction Oral Medications Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Erectile Dysfunction Oral Medications Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Erectile Dysfunction Oral Medications Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Erectile Dysfunction Oral Medications Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Erectile Dysfunction Oral Medications Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Erectile Dysfunction Oral Medications Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Erectile Dysfunction Oral Medications Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Erectile Dysfunction Oral Medications Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Erectile Dysfunction Oral Medications Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Erectile Dysfunction Oral Medications Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Erectile Dysfunction Oral Medications Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Erectile Dysfunction Oral Medications Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Erectile Dysfunction Oral Medications Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Erectile Dysfunction Oral Medications Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Erectile Dysfunction Oral Medications Sales Value by Region (2019-2024) & (%)
    Table 44. Global Erectile Dysfunction Oral Medications Sales Value by Region (2025-2030) & (%)
    Table 45. Global Erectile Dysfunction Oral Medications Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Erectile Dysfunction Oral Medications Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Erectile Dysfunction Oral Medications Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Erectile Dysfunction Oral Medications Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Erectile Dysfunction Oral Medications Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Erectile Dysfunction Oral Medications Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Erectile Dysfunction Oral Medications Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Erectile Dysfunction Oral Medications Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Erectile Dysfunction Oral Medications Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Erectile Dysfunction Oral Medications Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Erectile Dysfunction Oral Medications Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Erectile Dysfunction Oral Medications Sales Volume, (2025-2030) & (K Units)
    Table 57. Eli Lilly Company Information
    Table 58. Eli Lilly Introduction and Business Overview
    Table 59. Eli Lilly Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Eli Lilly Erectile Dysfunction Oral Medications Product Offerings
    Table 61. Eli Lilly Recent Development
    Table 62. Pfizer Company Information
    Table 63. Pfizer Introduction and Business Overview
    Table 64. Pfizer Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Pfizer Erectile Dysfunction Oral Medications Product Offerings
    Table 66. Pfizer Recent Development
    Table 67. Bayer Company Information
    Table 68. Bayer Introduction and Business Overview
    Table 69. Bayer Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Bayer Erectile Dysfunction Oral Medications Product Offerings
    Table 71. Bayer Recent Development
    Table 72. S.K. Chemicals Company Information
    Table 73. S.K. Chemicals Introduction and Business Overview
    Table 74. S.K. Chemicals Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. S.K. Chemicals Erectile Dysfunction Oral Medications Product Offerings
    Table 76. S.K. Chemicals Recent Development
    Table 77. Teva Pharma Company Information
    Table 78. Teva Pharma Introduction and Business Overview
    Table 79. Teva Pharma Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Teva Pharma Erectile Dysfunction Oral Medications Product Offerings
    Table 81. Teva Pharma Recent Development
    Table 82. Dong-A ST Company Information
    Table 83. Dong-A ST Introduction and Business Overview
    Table 84. Dong-A ST Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Dong-A ST Erectile Dysfunction Oral Medications Product Offerings
    Table 86. Dong-A ST Recent Development
    Table 87. Petros Pharmaceuticals Company Information
    Table 88. Petros Pharmaceuticals Introduction and Business Overview
    Table 89. Petros Pharmaceuticals Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Petros Pharmaceuticals Erectile Dysfunction Oral Medications Product Offerings
    Table 91. Petros Pharmaceuticals Recent Development
    Table 92. Seoul Pharma Company Information
    Table 93. Seoul Pharma Introduction and Business Overview
    Table 94. Seoul Pharma Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Seoul Pharma Erectile Dysfunction Oral Medications Product Offerings
    Table 96. Seoul Pharma Recent Development
    Table 97. BaiYunShan General Factory Company Information
    Table 98. BaiYunShan General Factory Introduction and Business Overview
    Table 99. BaiYunShan General Factory Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. BaiYunShan General Factory Erectile Dysfunction Oral Medications Product Offerings
    Table 101. BaiYunShan General Factory Recent Development
    Table 102. Yabang Pharmacy Company Information
    Table 103. Yabang Pharmacy Introduction and Business Overview
    Table 104. Yabang Pharmacy Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Yabang Pharmacy Erectile Dysfunction Oral Medications Product Offerings
    Table 106. Yabang Pharmacy Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Erectile Dysfunction Oral Medications Downstream Customers
    Table 110. Erectile Dysfunction Oral Medications Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Erectile Dysfunction Oral Medications Product Picture
    Figure 2. Global Erectile Dysfunction Oral Medications Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Erectile Dysfunction Oral Medications Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Erectile Dysfunction Oral Medications Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Erectile Dysfunction Oral Medications Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Erectile Dysfunction Oral Medications Report Years Considered
    Figure 7. Global Erectile Dysfunction Oral Medications Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Erectile Dysfunction Oral Medications Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Erectile Dysfunction Oral Medications Revenue in 2023
    Figure 10. Erectile Dysfunction Oral Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Sildenafil Picture
    Figure 12. Tadalafil Picture
    Figure 13. Others Picture
    Figure 14. Global Erectile Dysfunction Oral Medications Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Erectile Dysfunction Oral Medications Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Erectile Dysfunction Oral Medications Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Erectile Dysfunction Oral Medications Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Erectile Dysfunction Oral Medications Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Hospital Pharmacies
    Figure 20. Product Picture of Private Clinics
    Figure 21. Product Picture of Retail Pharmacies
    Figure 22. Product Picture of E-Commerce
    Figure 23. Global Erectile Dysfunction Oral Medications Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Erectile Dysfunction Oral Medications Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Erectile Dysfunction Oral Medications Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Erectile Dysfunction Oral Medications Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Erectile Dysfunction Oral Medications Price by Application (2019-2030) & (US$/Unit)
    Figure 28. North America Erectile Dysfunction Oral Medications Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Erectile Dysfunction Oral Medications Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Erectile Dysfunction Oral Medications Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Erectile Dysfunction Oral Medications Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Erectile Dysfunction Oral Medications Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Erectile Dysfunction Oral Medications Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Erectile Dysfunction Oral Medications Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Erectile Dysfunction Oral Medications Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Erectile Dysfunction Oral Medications Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Erectile Dysfunction Oral Medications Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Erectile Dysfunction Oral Medications Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Erectile Dysfunction Oral Medications Sales Volume (%), (2019-2030)
    Figure 40. United States Erectile Dysfunction Oral Medications Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Erectile Dysfunction Oral Medications Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Erectile Dysfunction Oral Medications Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Erectile Dysfunction Oral Medications Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Erectile Dysfunction Oral Medications Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Erectile Dysfunction Oral Medications Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Erectile Dysfunction Oral Medications Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Erectile Dysfunction Oral Medications Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Erectile Dysfunction Oral Medications Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Erectile Dysfunction Oral Medications Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Erectile Dysfunction Oral Medications Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Erectile Dysfunction Oral Medications Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Erectile Dysfunction Oral Medications Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Erectile Dysfunction Oral Medications Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Erectile Dysfunction Oral Medications Sales Value by Application (%), 2023 VS 2030
    Figure 61. Erectile Dysfunction Oral Medications Industrial Chain
    Figure 62. Erectile Dysfunction Oral Medications Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS